$HAO
Haoxi Health Technology Ltd Stock $hao

$hao Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 20-F Financial Statement

#000121390024091443 Filed on October 29, 2024

Income Statement

Concept	2024 Q2	2024	2023 Q2
Revenue	$48.52M	$48.52M	$28.23M
YoY Change	71.88%	71.88%	74.72%
Cost Of Revenue	$45.77M	$45.77M	$26.17M
YoY Change	74.91%	74.91%	68.73%
Gross Profit	$2.750M	$2.750M	$2.062M
YoY Change	33.38%	33.38%	217.86%
Gross Profit Margin	5.67%	5.67%	7.3%
Selling, General & Admin	$953.1K	$953.1K	$808.1K
YoY Change	17.95%	17.96%	191.28%
% of Gross Profit	34.65%	34.66%	39.19%
Research & Development	$79.99K	$79.99K	$58.16K
YoY Change	37.53%	37.91%	-43.27%
% of Gross Profit	2.91%	2.91%	2.82%
Depreciation & Amortization		$10.57K	$6.700K
YoY Change		25.8%	318.75%
% of Gross Profit		0.38%	0.32%
Operating Expenses	$1.033M	$1.033M	$866.3K
YoY Change	19.26%	19.3%	127.99%
Operating Profit	$1.717M	$1.717M	$1.196M
YoY Change	43.61%	43.58%	344.92%
Interest Expense	$34.91K	$34.91K	-$20.90K
YoY Change	-267.03%	-266.24%	109.84%
% of Operating Profit	2.03%	2.03%	-1.75%
Other Income/Expense, Net	-$16.91K	$18.00K	$15.50K
YoY Change	-209.1%	12.51%	1862.03%
Pretax Income	$1.735M	$1.735M	$1.190M
YoY Change	45.77%	45.82%	358.56%
Income Tax	$443.6K	$443.6K	$220.7K
% Of Pretax Income	25.56%	25.56%	18.54%
Net Earnings	$1.292M	$1.292M	$969.8K
YoY Change	33.2%	33.16%	296.48%
Net Earnings / Revenue	2.66%	2.66%	3.44%
Basic Earnings Per Share		$0.04
Diluted Earnings Per Share	$0.04	$0.04	$0.03
COMMON SHARES
Basic Shares Outstanding		30.60M shares
Diluted Shares Outstanding		30.60M shares

Balance Sheet

Concept	2024 Q2	2024	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.919M	$6.919M	$1.299M
YoY Change	432.65%	432.65%
Cash & Equivalents	$6.656M	$6.656M	$1.203M
Short-Term Investments	$263.5K	$263.5K	$95.80K
Other Short-Term Assets	$8.262M	$8.262M	$2.405M
YoY Change	243.58%	243.58%
Inventory
Prepaid Expenses	$3.351M
Receivables	$226.7K	$198.7K	-$29.60K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$15.38M	$15.38M	$3.674M
YoY Change	318.6%	318.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$126.7K	$126.7K	$233.4K
YoY Change	-45.7%	-45.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00	$556.8K
YoY Change	-100.0%	-100.0%
Total Long-Term Assets	$126.7K	$126.7K	$790.1K
YoY Change	-83.96%	-83.96%
TOTAL ASSETS
Total Short-Term Assets	$15.38M	$15.38M	$3.674M
Total Long-Term Assets	$126.7K	$126.7K	$790.1K
Total Assets	$15.51M	$15.51M	$4.464M
YoY Change	247.35%	247.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$653.7K	$653.7K	$54.70K
YoY Change	1095.05%	1095.05%
Accrued Expenses	$102.4K	$102.4K	$131.1K
YoY Change	-21.86%	-21.86%
Deferred Revenue
YoY Change
Short-Term Debt	$833.5K	$833.5K	$511.4K
YoY Change	62.99%	62.99%
Long-Term Debt Due			$27.34K
YoY Change
Total Short-Term Liabilities	$3.867M	$3.867M	$2.577M
YoY Change	50.07%	50.07%
LONG-TERM LIABILITIES
Long-Term Debt	$301.7K	$301.7K	$249.1K
YoY Change	21.11%	21.11%
Other Long-Term Liabilities	$66.37K	$66.37K	$72.10K
YoY Change	-7.95%	-7.95%
Total Long-Term Liabilities	$368.0K	$368.1K	$321.2K
YoY Change	14.58%	14.59%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.867M	$3.867M	$2.577M
Total Long-Term Liabilities	$368.0K	$368.1K	$321.2K
Total Liabilities	$4.235M	$4.235M	$2.898M
YoY Change	46.14%	46.14%
SHAREHOLDERS EQUITY
Retained Earnings	$723.2K		-$568.5K
YoY Change	-227.22%
Common Stock	$10.59M		$2.177M
YoY Change	386.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$11.27M	$11.27M	$1.567M
YoY Change
Total Liabilities & Shareholders Equity	$15.51M	$15.51M	$4.464M
YoY Change	247.35%	247.35%

Cashflow Statement

Concept	2024 Q2	2024	2023 Q2
OPERATING ACTIVITIES
Net Income	$1.292M	$1.292M	$969.8K
YoY Change	33.2%	33.16%	296.48%
Depreciation, Depletion And Amortization		$10.57K	$6.700K
YoY Change		25.8%	318.75%
Cash From Operating Activities		-$747.6K	-$1.077M
YoY Change		-14.28%	-1086.36%
INVESTING ACTIVITIES
Capital Expenditures		$55.37K	$41.90K
YoY Change		21.69%	381.61%
Acquisitions
YoY Change
Other Investing Activities		-$3.074M
YoY Change
Cash From Investing Activities		-$3.129M	-$41.90K
YoY Change		6777.04%	381.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$8.975M	$0.00
YoY Change		350.05%	-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$9.324M	-153.0K
YoY Change		417.23%	-318.26%
NET CHANGE
Cash From Operating Activities		-$747.6K	-1.077M
Cash From Investing Activities		-$3.129M	-41.90K
Cash From Financing Activities		$9.324M	-153.0K
Net Change In Cash		$5.453M	-1.272M
YoY Change		516.11%	-845.6%
FREE CASH FLOW
Cash From Operating Activities		-$747.6K	-$1.077M
Capital Expenditures		$55.37K	$41.90K
Free Cash Flow		-$802.9K	-$1.119M
YoY Change		-12.5%	-1213.43%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Document Type DocumentType	20-F
CY2024	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-41933
CY2024	dei	Entity Registrant Name EntityRegistrantName	Haoxi Health Technology Limited
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	Room 801, Tower C, Floor 8, Building 103
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	Huizhongli, Chaoyang District
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Beijing
CY2024	dei	Entity Address Country EntityAddressCountry	CN
CY2024	dei	Security12b Title Security12bTitle	Class A Ordinary Shares, par value US$0.0001 per share
CY2024	dei	Trading Symbol TradingSymbol	HAO
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024	dei	Auditor Firm AuditorFirmId	2388
CY2024	dei	Auditor Name AuditorName	Wei, Wei & Co., LLP
CY2024	dei	Auditor Location AuditorLocation	New York
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6655734	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1203203	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	226747	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7748	usd
CY2024Q2	us-gaap	Supplies Supplies	5174302	usd
CY2023Q2	us-gaap	Supplies Supplies	2404680	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3323047	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	58474	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	15379830	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	3674105	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	126743	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	143836	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	89544	usd
CY2023Q2	us-gaap	Deferred Costs DeferredCosts	556752	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	126743	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	790132	usd
CY2024Q2	us-gaap	Assets Assets	15506573	usd
CY2023Q2	us-gaap	Assets Assets	4464237	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	833521	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	511409	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	653694	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	27312	usd
CY2024Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	1185130	usd
CY2023Q2	us-gaap	Customer Advances Current CustomerAdvancesCurrent	1493947	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1044532	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	328093	usd
CY2024Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	102436	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	41517	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	41075	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	37145	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	89544	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	27344	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3866575	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2576521	usd
CY2024Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	66365	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	72104	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	301678	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	249107	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	368043	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	321211	usd
CY2024Q2	us-gaap	Liabilities Liabilities	4234618	usd
CY2023Q2	us-gaap	Liabilities Liabilities	2897732	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	10589916	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2176796	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	723207	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-568460	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-44392	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-44779	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	11271955	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1566505	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15506573	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4464237	usd
CY2024	us-gaap	Revenues Revenues	48519836	usd
CY2023	us-gaap	Revenues Revenues	28229149	usd
CY2022	us-gaap	Revenues Revenues	16156865	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	45769459	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	26167083	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	15508144	usd
CY2024	us-gaap	Gross Profit GrossProfit	2750377	usd
CY2023	us-gaap	Gross Profit GrossProfit	2062066	usd
CY2022	us-gaap	Gross Profit GrossProfit	648721	usd
CY2024	us-gaap	Selling Expense SellingExpense	41613	usd
CY2023	us-gaap	Selling Expense SellingExpense	32133	usd
CY2022	us-gaap	Selling Expense SellingExpense	37488	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	911531	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	775961	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	239941	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	79985	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	58161	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	102524	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	1033129	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	866255	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	379953	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	1717248	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	1195811	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	268768	usd
CY2024	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	41186	usd
CY2023	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	20902	usd
CY2022	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	9961	usd
CY2024	us-gaap	Investment Income Interest InvestmentIncomeInterest	76096	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-16909	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	15496	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	788	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	18001	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5406	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-9173	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1735249	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1190405	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	259595	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	443582	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	220653	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15008	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	1291667	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	969752	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	244587	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	1291667	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	969752	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	244587	usd
CY2024	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	387	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	68180	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	63037	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1292054	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	1037932	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	307624	usd
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30600000	shares
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30600000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27613333	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27613333	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25000000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25000000	shares
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-1931018	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	244587	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	157709	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	63037	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1465685	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	969752	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1994258	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	68180	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	1566505	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	1291667	usd
CY2024	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8413396	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	387	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	11271955	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	1291667	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	969752	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	244587	usd
CY2024	us-gaap	Depreciation Depreciation	10567	usd
CY2023	us-gaap	Depreciation Depreciation	8393	usd
CY2022	us-gaap	Depreciation Depreciation	2212	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	217900	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4279	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-665618	usd
CY2024	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	2723828	usd
CY2023	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	2473178	usd
CY2022	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-439423	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	175298	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-51862	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-8088	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	623168	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1201034	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1604129	usd
CY2024	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-328077	usd
CY2023	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	1393774	usd
CY2022	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances	-369220	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	60069	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	14406	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-31572	usd
CY2024	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	708658	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	330316	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-29025	usd
CY2024	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	90377	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	7618	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-90409	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	90377	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	29402	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-87689	usd
CY2024	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	3398	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	16072	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-4063	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-747576	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-872132	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-675361	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	55367	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45500	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8698	usd
CY2024	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	3073684	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3129051	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-45500	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8698	usd
CY2024	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	478404	usd
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	453123	usd
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	329869	usd
CY2024	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	115934	usd
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	345604	usd
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	52062	usd
CY2024	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-14329	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	21038	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-811260	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1302752	usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8975416	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1994258	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	163920	usd
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	259311	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	579558	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9323557	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1802568	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	933219	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5601	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24756	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-11534	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5452531	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	909692	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	237626	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1203203	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293511	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	55886	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6655734	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1203203	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293511	usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	27570	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7388	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	37265	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	19775	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	206	usd
CY2023	hao	Operating Right Of Use Asset OperatingRightOfUseAsset	89544	usd
CY2022	hao	Operating Right Of Use Asset OperatingRightOfUseAsset	88528	usd
CY2024	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2022-08-05
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>(c) Use of estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing the CFS in conformity with U.S. GAAP, management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the dates of the CFS, as well as the reported amounts of revenue and expenses during the reporting periods. Significant items subject to such estimates and assumptions include, but are not limited to, the assessment of the allowance for doubtful accounts, useful lives of property and equipment and intangible assets, the recoverability of long-lived assets, uncertain tax position, purchase price allocations for business combination, impairment assessment for goodwill and realization of deferred tax assets. Actual results could differ from those estimates.</p>
CY2024	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	94963	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	86186	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	41144	usd
CY2024	hao	Value Added Tax Percentage ValueAddedTaxPercentage	0.06	pure
CY2024Q2	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	7.1268	pure
CY2023Q2	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	7.2258	pure
CY2022Q2	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	6.7114	pure
CY2024Q2	us-gaap	Derivative Forward Exchange Rate1 DerivativeForwardExchangeRate1	7.1592	pure
CY2023Q2	us-gaap	Derivative Forward Exchange Rate1 DerivativeForwardExchangeRate1	6.9415	pure
CY2022Q2	us-gaap	Derivative Forward Exchange Rate1 DerivativeForwardExchangeRate1	6.4571	pure
CY2015Q2	us-gaap	Security Deposit Liability SecurityDepositLiability	500000	cny
CY2015Q2	us-gaap	Security Deposit Liability SecurityDepositLiability	70000	usd
CY2024Q2	hao	Advances For Products And Services Purchasing From Third Parties AdvancesForProductsAndServicesPurchasingFromThirdParties	5174302	usd
CY2023Q2	hao	Advances For Products And Services Purchasing From Third Parties AdvancesForProductsAndServicesPurchasingFromThirdParties	2404680	usd
CY2024Q2	us-gaap	Supplies Supplies	5174302	usd
CY2023Q2	us-gaap	Supplies Supplies	2404680	usd
CY2024Q2	hao	Loans To Third Parties LoansToThirdParties	3087665	usd
CY2024Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	263445	usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	95840	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3351110	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	28063	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	37366	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3323047	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	58474	usd
CY2024	us-gaap	Short Term Debt Terms ShortTermDebtTerms	1 year
CY2024Q2	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.08	pure
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	37366	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2980	usd
CY2024	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	-9303	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	34386	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	28063	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	37366	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	156448	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	154305	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	29705	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10469	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	126743	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	143836	usd
CY2024Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	653694	usd
CY2023Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	27312	usd
	us-gaap	Payments For Rent PaymentsForRent	431460	cny
	us-gaap	Payments For Rent PaymentsForRent	65103	usd
CY2024	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	On June 21, 2021, Haoxi BJ extended the lease to June 30, 2023
CY2021Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	675120	cny
CY2021Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	104555	usd
CY2022Q3	us-gaap	Payments For Rent PaymentsForRent	660000	cny
CY2022Q3	us-gaap	Payments For Rent PaymentsForRent	92189	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	89544	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	89544	usd
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	176676	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	182218	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0475	pure
CY2023Q1	hao	Down Payment DownPayment	200000	cny
CY2023Q1	hao	Down Payment DownPayment	28063	usd
CY2023Q1	hao	Loan Repayment Period LoanRepaymentPeriod	P3Y
CY2023Q1	us-gaap	Repayments Of Debt Maturing In More Than Three Months RepaymentsOfDebtMaturingInMoreThanThreeMonths	24698	cny
CY2023Q1	us-gaap	Repayments Of Debt Maturing In More Than Three Months RepaymentsOfDebtMaturingInMoreThanThreeMonths	3466	usd
CY2024	us-gaap	Financing Interest Expense FinancingInterestExpense	5706	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4336	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	1110	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	3226	usd
CY2024	us-gaap	Debt Instrument Term DebtInstrumentTerm	P20M
CY2024	hao	Required Rate Of Return Required By Lender Rate RequiredRateOfReturnRequiredByLenderRate	0.0699	pure
CY2024	us-gaap	Repayments Of Debt RepaymentsOfDebt	70701	usd
CY2024Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	833521	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	511409	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	301678	usd
CY2024Q2	us-gaap	Loans Payable LoansPayable	115934	usd
CY2024Q2	us-gaap	Unsecured Debt UnsecuredDebt	395475	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	511409	usd
CY2024	us-gaap	Interest Expense Debt InterestExpenseDebt	41186	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	19775	usd
CY2024	hao	Future Income Tax Description FutureIncomeTaxDescription	The PRC State Tax Bureau further stipulates that annual taxable income less than RMB 3 million ($420,000) is subject to an effective EIT rate of 5% from January 1 to December 31, 2027.
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	443582	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	220653	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15008	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.25	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.065	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.192	pure
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.185	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.058	pure
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	142115	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	142115	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	384553	usd
CY2024Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	142115	usd
CY2023Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	142115	usd
CY2022Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	384553	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	142115	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	142115	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	384553	usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	142115	usd
CY2024Q2	hao	Value Added Tax Payable ValueAddedTaxPayable	366720	usd
CY2023Q2	hao	Value Added Tax Payable ValueAddedTaxPayable	75133	usd
CY2022Q2	hao	Value Added Tax Payable ValueAddedTaxPayable	-24298	usd
CY2024Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	675842	usd
CY2023Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	250868	usd
CY2022Q2	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	35490	usd
CY2024Q2	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	1796	usd
CY2023Q2	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	2092	usd
CY2022Q2	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	410	usd
CY2024Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	1044357	usd
CY2023Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	328093	usd
CY2022Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	11601	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2024Q2	us-gaap	Deferred Costs DeferredCosts		usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest		usd
CY2023	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		usd
CY2024	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
CY2024	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2024	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2024	hao	Operating Right Of Use Asset OperatingRightOfUseAsset		usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2023Q2	hao	Loans To Third Parties LoansToThirdParties		usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2024Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	00000
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001954594

Files In Submission

Name	View Source	Status
hao-20240630_cal.xml	Edgar Link	unprocessable
hao-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
hao-20240630_lab.xml	Edgar Link	unprocessable
0001213900-24-091443-index-headers.html	Edgar Link	pending
0001213900-24-091443-index.html	Edgar Link	pending
0001213900-24-091443.txt	Edgar Link	pending
0001213900-24-091443-xbrl.zip	Edgar Link	pending
ea0218492-20f_haoxi.htm	Edgar Link	pending
ea021849201ex11-2_haoxi.htm	Edgar Link	pending
ea021849201ex12-1_haoxi.htm	Edgar Link	pending
ea021849201ex12-2_haoxi.htm	Edgar Link	pending
ea021849201ex13-1_haoxi.htm	Edgar Link	pending
ea021849201ex13-2_haoxi.htm	Edgar Link	pending
ea021849201ex15-1_haoxi.htm	Edgar Link	pending
ea021849201ex15-2_haoxi.htm	Edgar Link	pending
ea021849201ex2-5_haoxi.htm	Edgar Link	pending
ea021849201ex97-1_haoxi.htm	Edgar Link	pending
ex15-1_001.jpg	Edgar Link	pending
ex15-2_001.jpg	Edgar Link	pending
ex15-2_002.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hao-20240630.xsd	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
ea0218492-20f_haoxi_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
hao-20240630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HAO
Haoxi Health Technology Ltd Stock $hao

2024 Q2 Form 20-F Financial Statement

#000121390024091443 Filed on October 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAO Haoxi Health Technology Ltd Stock $hao

2024 Q2 Form 20-F Financial Statement

#000121390024091443 Filed on October 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HAO
Haoxi Health Technology Ltd Stock $hao